MOPH

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
R05DB13	SINECOD	B	Butamirate dihydrogenocitrate - 15mg/10ml	15mg/10ml	Syrup, sugar free	521,411 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
R05DB13	SINECOD	B	Butamirate dihydrogenocitrate - 5mg/ml	5mg/ml	Drops	287,582 L.L
N03AG04	SABRIL	B	Vigabatrin - 500mg	500mg	Tablet, film coated	2,988,706 L.L
H01CB02	SANDOSTATIN	B	Octreotide - 0.1mg/ml	0.1mg/ml	Injectable solution	1,038,790 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	34,573,047 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	51,860,213 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 90mg	90mg	Injectable solution	48,383,450 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 120mg	120mg	Injectable solution	57,492,826 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	159,720,381 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	170,735,579 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	174,040,139 L.L